Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Heliyon|June 13, 2020
Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cellsEmanuela Chiarella, Bruna Codispoti, Annamaria Aloisio, et al.Stem Cells (Dayton, Ohio)|September 29, 2009
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome geneValeria Leuci, Loretta Gammaitoni, Sonia Capellero, et al.Cells|September 28, 2023
GPER1 Activation Exerts Anti-Tumor Activity in Multiple MyelomaMaria Eugenia Gallo Cantafio, Roberta Torcasio, Francesca Scionti, et al.The International Journal of Biochemistry & Cell Biology|June 5, 2007
Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cellsHeather M Bond, Maria Mesuraca, Nicola Amodio, et al.Stem Cell Reviews and Reports|June 26, 2018
ZNF521 Has an Inhibitory Effect on the Adipogenic Differentiation of Human Adipose-Derived Mesenchymal Stem CellsEmanuela Chiarella, Annamaria Aloisio, Bruna Codispoti, et al.Journal of Translational Medicine|August 15, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclaxIlenia Valentino, Maria Eugenia Gallo Cantafio, Roberta Torcasio, et al.Blood|August 26, 2004
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cellsEnnio Carbone, Paola Neri, Maria Mesuraca, et al.Cell Death & Disease|September 28, 2019
The stem cell-associated transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathwayStefania Scicchitano, Marco Giordano, Valeria Lucchino, et al.Cell Cycle (Georgetown, Tex.)|May 20, 2011
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitorsTiziana Mega, Michela Lupia, Nicola Amodio, et al.Carcinogenesis|January 22, 2014
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferationMichele Massimino, Maria Letizia Consoli, Maria Mesuraca, et al.Pageof 4